Skip to content
OpenCapital
Get started

Ultragenyx Pharmaceutical RARE Market capitalization

Market capitalization at other companies

Eli Lilly logo
Eli LillyLLY
$821.68B+10.8%
Amgen logo
AmgenAMGN
$189.67B+13.3%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$12.4B+159%
Arrowhead Research logo
Arrowhead ResearchARWR
$8.78B+402%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$4.57B+56.4%
Moderna logo
ModernaMRNA
$20.15B+83.8%

Other financials

Income statement

See full
Revenue$136.0M-2.2%
Operating income-$169.0M-18.2%
Net income-$185.0M-22.5%
EPS (diluted)-$1.84-17.2%

Balance sheet

See full
Cash & equivalents$175.0M+37.8%
Total debt$36.0M-10.8%
Total equity-$236.0M-264%
Total assets$1.3B-1.2%

Cash flow

See full
Operating cash flow-$197.0M-18.7%
CapEx$1.0M0.0%
Free cash flow-$198.0M-18.6%

Valuation

See full
P/S4.2×-3.7×

Profitability

See full
Gross margin97.2%—
Operating margin-83.8%-3.0pp
Net margin-90.9%-2.1pp
FCF margin-75.1%+10.7pp

Returns & leverage

See full
Return on equity-325.6%+36.9pp
Debt / equity3.7×—
Current ratio2×-0.4×

Where this comes from

Computed from the period-end share price: $2.06B.

The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ultragenyx Pharmaceutical's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ultragenyx Pharmaceutical's market capitalization?
Ultragenyx Pharmaceutical (RARE) reported market capitalization of $2.06B in Q1 2026.
How has Ultragenyx Pharmaceutical's market capitalization changed year-over-year?
Ultragenyx Pharmaceutical's market capitalization decreased by 39.4% year-over-year, from $3.4B to $2.06B.
What is the long-term trend for Ultragenyx Pharmaceutical's market capitalization?
Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's market capitalization has grown at a -25.1% compound annual growth rate (CAGR), from $9.44B to $2.22B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.